These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10904113)

  • 1. Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics.
    Sahu A; Lambris JD
    Immunopharmacology; 2000 Aug; 49(1-2):133-48. PubMed ID: 10904113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The possibilities and pitfalls for anti-complement therapies in inflammatory diseases.
    Mizuno M; Morgan BP
    Curr Drug Targets Inflamm Allergy; 2004 Mar; 3(1):87-96. PubMed ID: 15032645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling the complement system in inflammation.
    Kirschfink M
    Immunopharmacology; 1997 Dec; 38(1-2):51-62. PubMed ID: 9476114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement therapeutics; history and current progress.
    Morgan BP; Harris CL
    Mol Immunol; 2003 Sep; 40(2-4):159-70. PubMed ID: 12914822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting complement in therapy.
    Kirschfink M
    Immunol Rev; 2001 Apr; 180():177-89. PubMed ID: 11414360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of complement therapeutics for inhibition of immune-mediated red cell destruction.
    Yazdanbakhsh K
    Transfusion; 2005 Aug; 45(2 Suppl):122S-9S. PubMed ID: 16086799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic inhibition of the complement system. Y2K update.
    Asghar SS; Pasch MC
    Front Biosci; 2000 Sep; 5():E63-81. PubMed ID: 10966868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical applications of recombinant complement inhibitors].
    Lipiński D; Pławski A; Juzwa W; Zeyland J; Słomski R
    Pol Merkur Lekarski; 2004 Jun; 16(96):571-5. PubMed ID: 15510900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic uses of recombinant complement protein inhibitors.
    Kalli KR; Hsu P; Fearon DT
    Springer Semin Immunopathol; 1994; 15(4):417-31. PubMed ID: 8153875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial targeting and enhanced antiinflammatory effects of complement inhibitors possessing sialyl Lewisx moieties.
    Mulligan MS; Warner RL; Rittershaus CW; Thomas LJ; Ryan US; Foreman KE; Crouch LD; Till GO; Ward PA
    J Immunol; 1999 Apr; 162(8):4952-9. PubMed ID: 10202042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of targeting the complement cascade in critical care medicine.
    Bhole D; Stahl GL
    Crit Care Med; 2003 Jan; 31(1 Suppl):S97-104. PubMed ID: 12544983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: complement activation and therapeutic approaches.
    Chen S; Frederickson RC; Brunden KR
    Neurobiol Aging; 1996; 17(5):781-7. PubMed ID: 8892352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic inhibition of the early phase of complement activation.
    Roos A; Ramwadhdoebé TH; Nauta AJ; Hack CE; Daha MR
    Immunobiology; 2002 Sep; 205(4-5):595-609. PubMed ID: 12396018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation following oxidative stress.
    Collard CD; Lekowski R; Jordan JE; Agah A; Stahl GL
    Mol Immunol; 1999; 36(13-14):941-8. PubMed ID: 10698348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological manipulation of the complement system in human diseases.
    Asghar SS
    Front Biosci; 1996 Mar; 1():e15-25. PubMed ID: 9159241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailoring anti-complement therapeutics.
    Harris CL; Fraser DA; Morgan BP
    Biochem Soc Trans; 2002 Nov; 30(Pt 6):1019-26. PubMed ID: 12440965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane-targeted complement inhibitors.
    Smith GP; Smith RA
    Mol Immunol; 2001 Aug; 38(2-3):249-55. PubMed ID: 11532286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement: the Iceman of immunology?
    Würzner R
    Immunopharmacology; 1997 Dec; 38(1-2):63-4. PubMed ID: 9476115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic complement inhibition in complement-mediated hemolytic anemias: Past, present and future.
    Risitano AM; Marotta S
    Semin Immunol; 2016 Jun; 28(3):223-40. PubMed ID: 27346521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of the complement system currently in development for cardiovascular disease.
    Pugsley MK; Abramova M; Cole T; Yang X; Ammons WS
    Cardiovasc Toxicol; 2003; 3(1):43-70. PubMed ID: 12668890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.